Ascension Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | $1.61M | Sell |
9,362
-650
| -6% | -$111K | 0.84% | 42 |
|
2024
Q1 | $1.82M | Buy |
+10,012
| New | +$1.82M | 0.98% | 37 |
|
2023
Q2 | $1.42M | Buy |
+10,512
| New | +$1.42M | 0.87% | 46 |
|
2022
Q4 | $1.7M | Hold |
10,512
| – | – | 1.23% | 36 |
|
2022
Q3 | $1.41M | Hold |
10,512
| – | – | 1.11% | 41 |
|
2022
Q2 | $1.61M | Buy |
+10,512
| New | +$1.61M | 1.19% | 39 |
|
2021
Q4 | $1.45M | Sell |
10,700
-300
| -3% | -$40.6K | 0.86% | 47 |
|
2021
Q3 | $1.19M | Sell |
11,000
-50
| -0.5% | -$5.4K | 0.78% | 53 |
|
2021
Q2 | $1.25M | Sell |
11,050
-394
| -3% | -$44.4K | 0.82% | 53 |
|
2021
Q1 | $1.21M | Buy |
+11,444
| New | +$1.21M | 0.84% | 52 |
|
2020
Q4 | – | Sell |
-11,569
| Closed | -$1.01M | – | 30 |
|
2020
Q3 | $1.01M | Buy |
+11,569
| New | +$1.01M | 0.81% | 54 |
|
2020
Q1 | $878K | Sell |
11,519
-190
| -2% | -$14.5K | 0.91% | 49 |
|
2019
Q4 | $1.04M | Sell |
11,709
-150
| -1% | -$13.3K | 0.89% | 51 |
|
2019
Q3 | $898K | Sell |
11,859
-1,150
| -9% | -$87.1K | 0.83% | 54 |
|
2019
Q2 | $946K | Sell |
13,009
-395
| -3% | -$28.7K | 0.83% | 54 |
|
2019
Q1 | $1.08M | Sell |
13,404
-225
| -2% | -$18.1K | 0.97% | 52 |
|
2018
Q4 | $1.26M | Hold |
13,629
| – | – | 1.28% | 38 |
|
2018
Q3 | $1.29M | Sell |
13,629
-310
| -2% | -$29.3K | 1.13% | 43 |
|
2018
Q2 | $1.29M | Buy |
13,939
+620
| +5% | +$57.4K | 1.18% | 38 |
|
2018
Q1 | $1.26M | Hold |
13,319
| – | – | 1.15% | 39 |
|
2017
Q4 | $1.29M | Buy |
+13,319
| New | +$1.29M | 1.17% | 41 |
|